SIGN UP
LOG IN
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
Benzinga·12/18/2024 09:34:22
Listen to the news
Shares of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) rose sharply in today's pre-market trading after the company announced it will report on December 18 interim data from its Phase 1 clinical trial evaluating Soquelitinib in patients with moderate to severe atopic dermatitis.
Corvus Pharmaceuticals shares jumped 22.5% to $9.06 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
- ParaZero Technologies Ltd. (NASDAQ:PRZO) gained 88.8% to $2.89 in pre-market trading after gaining 5% on Tuesday. ParaZero Technologies regained Nasdaq compliance.
- Vast Renewables Limited (NASDAQ:VSTE) climbed 68.4% to $2.19 in pre-market trading after declining over 6% on Tuesday.
- Nukkleus Inc. (NASDAQ:NUKK) gained 55.1% to $18.42 in pre-market trading. Nukkleus shares jumped 755% on Tuesday after the company announced it has acquired a 51% controlling stake in Star 26 Capital.
- 1847 Holdings LLC (NASDAQ:EFSH) gained 46% to $0.3278 in pre-market trading.
- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) rose 33% to $0.4417 in pre-market trading after dipping 37% on Tuesday.
- Rezolve AI Limited (NASDAQ:RZLV) gained 30.1% to $4.28 in pre-market trading.
- CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) gained 27.7% to $0.0780 in pre-market trading after jumping 20% on Tuesday.
- Richtech Robotics Inc. (NASDAQ:RR) gained 26% to $1.55 in pre-market trading after jumping over 26% on Tuesday.
- CommScope Holding Company, Inc (NASDAQ:COMM) rose 9.1% to $6.12 in pre-market trading.
Losers
- NewGenIvf Group Limited (NASDAQ:NIVF) shares tumbled 29.9% to $0.30 in pre-market trading after jumping 56% on Tuesday.
- Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) declined 24% to $0.38 in pre-market trading after jumping 87% on Tuesday.
- KWESST Micro Systems Inc (NASDAQ:KWE) shares fell 15.5% to $0.71 in pre-market trading after surging over 15% on Tuesday.
- Applied DNA Sciences, Inc. (NASDAQ:APDN) shares fell 14.7% to $0.1962 in pre-market trading after reporting weak quarterly sales.
- authID Inc. (NASDAQ:AUID) dipped 13.8% to $5.00 in pre-market trading following a 4% decline in the previous session.
- FS Bancorp, Inc. (NASDAQ:FSBW) fell 13.4% to $39.01 in pre-market trading.
- Portage Biotech Inc. (NASDAQ:PRTG) fell 12.5% to $7.90 in today's pre-market trading after jumping 182% on Tuesday.
- SHL Telemedicine Ltd. (NASDAQ:SHLT) fell 10% to $3.15 in pre-market trading following a 20% surge on Tuesday.
- Southern States Bancshares, Inc. (NASDAQ:SSBK) fell 9.6% to $32.00 in pre-market trading.
- Worthington Steel, Inc. (NYSE:WS) shares dipped 8.6% to $36.00 in pre-market trading.
Now Read This:
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.